Literature DB >> 30841414

Daphnoretin: An invasion inhibitor and apoptosis accelerator for colon cancer cells by regulating the Akt signal pathway.

Suyang Yu1, Hong Guo2, Xin Gao3, Meng Li1, Honglei Bian1.   

Abstract

The regulation of Daphnoretin on specific tumours (e.g. cervical cancer, lung cancer, osteosarcoma) has been documented, which still remains unclear for colon cancer cells. Our study explored the suppression of Daphnoretin and its molecular mechanism on the proliferation, apoptosis, invasion and migration of human colon cancer cell line HCT116. Our report showed the activity of HCT116 declined with time- and dose- dependence after Daphnoretin intervention, and a rise in G0/G1 ratio and decrease in G2/M ratio was observed. Daphnoretin-treated HCT116 had declined invasion and migration, increased apoptosis rate, and variations in gene expressions related to the Akt signal pathway. Those results indicated that Daphnoretin can inhibit the proliferation, invasion, and migration of HCT116 and promote its apoptosis by regulating the activity of Akt signal pathway.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  AKT signal pathway; Apoptosis; Colon cancer; Daphnoretin; Invasion

Mesh:

Substances:

Year:  2019        PMID: 30841414     DOI: 10.1016/j.biopha.2019.01.003

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  3 in total

1.  Metformin Suppresses the Proliferation and Promotes the Apoptosis of Colon Cancer Cells Through Inhibiting the Expression of Long Noncoding RNA-UCA1.

Authors:  Jianbo Guo; Yan Li; He Duan; Lu Yuan
Journal:  Onco Targets Ther       Date:  2020-05-14       Impact factor: 4.147

2.  Daphnoretin induces reactive oxygen species-mediated apoptosis in melanoma cells.

Authors:  Hui Wang; Xue Hu; Minjing Li; Zhaohai Pan; Defang Li; Qiusheng Zheng
Journal:  Oncol Lett       Date:  2021-04-08       Impact factor: 2.967

3.  A nano-preparation approach to enable the delivery of daphnoretin to potentiate the therapeutical efficacy in hepatocellular cancer.

Authors:  Guanglin Zhu; Bing Wang; Guo Feng; Zhirong Zhou; Wei Li; Wen Liu; Hongmei Su; Wenjing Wang; Tiejie Wang; Xie-An Yu
Journal:  Front Pharmacol       Date:  2022-09-28       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.